Loại tài liệu:    Chỉ tìm trong: 
51-60 trong số 206 kết quả
A Phase I Trial of the Pharmacokinetic Interaction Between Cannabidiol and Tacrolimus
Tác giả: Gerald C So, Jessica Bo Li Lu, Travis R Beamon, Zachary Cowsert, Jennifer S Stuart, Zeruesenay Desta, Michael T Eadon, Sachiko Koyama, Ying-Hua Cheng, Debora L Gisch, Kelsey McClara, Paul R Dexter, Asif A Sharfuddin, Jumar Etkins, Emma M Tillman
Xuất bản: United States: Clinical pharmacology and therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  303.35
 
Oxygenation Effects of Antihypertensive Agents in Intensive Care: A Prospective Comparative Study of Nicardipine and Ura...
Tác giả: Florimond Suard, Martin Mombrun, Richard Descamps, Marc-Olivier Fischer, Jean-Luc Hanouz, Jean-Baptiste Decros, Sébastien Derville, Clément Gakuba, Gulbhar Al Issa, Caroline Menard, Basile Chretien
Xuất bản: United States: Clinical pharmacology and therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  953.3
 
Current Use of Physiologically Based Pharmacokinetic modeling in New Medicinal Product Approvals at EMA
Tác giả: Polly Paul, Pieter J Colin, Flora Musuamba Tshinanu, Carolien Versantvoort, Efthymios Manolis, Kevin Blake
Xuất bản: United States: Clinical pharmacology and therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  242.34
 
Trends of Publication of Negative Trials Over Time
Tác giả: Bruno Laviolle, Clara Locher, Eric Bellissant, Florian Naudet, Jean-Sébastien Allain, Quentin Le Cornu, Pierre Charpentier, Marie Lefebvre, Clémence Le Pape, Cyril Leven, Clément Palpacuer, Clémence Pontoizeau
Xuất bản: United States: Clinical pharmacology and therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  391.412
 
A Novel Two-Part Mixture Model for the Incidence and Time Course of Cytokine Release Syndrome After Elranatamab Dosing i...
Tác giả: Donald Irby, Jennifer Hibma, Mohamed Elmeliegy, Diane Wang, Erik Vandendries, Kamrine Poels, Blerta Shtylla, Jason H Williams
Xuất bản: United States: Clinical pharmacology and therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  302.222
 
Correction to "Clinical Pharmacology and Translational Considerations in the Development of CRISPR-Based Therapies"
Tác giả:
Xuất bản: United States: Clinical pharmacology and therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  707.4
 
Impact of Regulatory Post-Market Safety Advisories on Prescribing Practices: An Interrupted Time Series Analysis
Tác giả: Seonji Kim, Subin Kim, Chungsoo Kim, Junhyuk Chang, Rae Woong Park, Kyung Won Kim, Seng Chan You
Xuất bản: United States: Clinical pharmacology and therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  612.665
 
Drug-Event Pairs as Indicators for the Detection of Adverse Drug Reactions during Hospitalization in Routinely Collected...
Tác giả: Anna Maria Wermund, Tobias Dreischulte, Wolfgang Fehrmann, Annette Haerdtlein, Ulrich Jaehde, Clara Weglage
Xuất bản: United States: Clinical pharmacology and therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  496.3985
 
Leading the Way: Multi-Drug Resistance Protein (MDR1) and Clinical Pharmacology-Commentary on Kim et al
Tác giả: Kathleen M Giacomini
Xuất bản: United States: Clinical pharmacology and therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  004.358
 
Deciphering the Relative Contribution of CYP3A4 Versus P-Glycoprotein for the Shared Substrate Cyclosporine-Commentary o...
Tác giả: Ingolf Cascorbi, Richard B Kim
Xuất bản: United States: Clinical pharmacology and therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  620.11245
 

Truy cập nhanh danh mục